Related Experiment Video
Updated: May 11, 2025

03:09
Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays
Published on: August 9, 2024
513
Unlocking GPCR-ligand interactions: Measuring binding affinities with thermal shift assay
Dmitrii Dashevskii1, Aleksandra Luginina1, Ivan Maslov1
1Research Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Moscow, Russia.
Protein Science : a Publication of the Protein Society
|April 18, 2025
Summary
A novel application of the thermal shift assay (TSA) offers a cost-effective method for measuring drug binding to G protein-coupled receptors (GPCRs). This user-friendly technique provides reproducible results, advancing drug discovery research.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- G protein-coupled receptors (GPCRs) are a large superfamily of transmembrane proteins, crucial for drug discovery.
- Current methods for measuring GPCR ligand binding are complex and expensive.
- Understanding receptor-ligand interactions is vital for developing new therapeutics.
Purpose of the Study:
- To introduce and validate the thermal shift assay (TSA) as a cost-effective and user-friendly method for determining GPCR ligand binding affinities.
- To assess the reproducibility and accuracy of the TSA method for GPCR research.
Main Methods:
- Application of the thermal shift assay (TSA) to measure ligand binding to the human A2A adenosine receptor.
- Utilized three mathematical models for TSA data approximation and analysis.
- Validated the method using antagonists for the cysteinyl leukotriene GPCR (CysLT1R).
Main Results:
- Determined binding constants for four orthosteric ligands and allosteric sodium for the human A2A adenosine receptor.
- The TSA method demonstrated high reproducibility and agreement with existing literature data.
- Successful validation using CysLT1R antagonists confirmed the assay's applicability.
Conclusions:
- The thermal shift assay (TSA) is a suitable and reliable method for investigating ligand interactions with GPCRs.
- This approach offers a cost-effective alternative for drug discovery and pharmacological research.
- The TSA method can be applied to various types of GPCR ligands, enhancing therapeutic development.

